Bernd Muehlenweg
Non Executive Director @Sernova
Signup · Get unlimited contacts
WORK HISTORY
Non Executive Director @Sernova
Sernova (TSX: SVA)(OTCQB: SEOVF) is a clinical-stage biotechnology company that is advancing a novel cell therapy platform for the treatment of chronic diseases. The lead program is evaluating Sernova\'s Cell Pouch System™ as a potential ‘functional cure’ for insulin-dependent diabetes. In addition, Sernova has a pipeline that includes preclinical programs in hemophilia A and hypothyroidism.
EDUCATION
Technical University of Munich
Ph.D., Oncology, Biochemistry
St. Galler Business School
Management
Bielefeld University
Dipl. Chem., Chemistry, Biochemistry
Dublin City University
Dipl. Chem., Biophysical Chemistry
SKILLS
ABOUT BERND MUEHLENWEG
Experienced biopharma executive with a strong track record in global business development, corporate strategy, and alliance management.Passionate about translating cutting-edge science into impactful therapies, I bring over two decades of leadership in building partnerships, securing strategic deals, and advancing novel platforms and assets from discovery to clinical stage. I thrive in fast-paced environments where innovation meets execution — always with a focus on patient-centric outcomes.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.